(marketscreener.com) Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC are investigating the proposed sale of Provention Bio, Inc. to Sanofi . Under the terms of the proposed transaction, shareholders of Provention will receive only $25.00 in cash for each share of Provention that they own. KSF is seeking...https://www.marketscreener.com/quote/stock/PROVENTION-BIO-INC-45031992/news/PROVENTION-BIO-INVESTOR-ALERT-by-the-Former-Attorney-General-of-Louisiana-Kahn-Swick-Foti-LLC-In-43372550/?utm_medium=RSS&utm_content=20230329
Provention Bio is a New Jersey-based biopharmaceutical company that researches and develops novel therapeutics for the treatment of autoimmune diseases.